Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia.

Youlden DR, Baade PD, Walker R, Pyke CM, Roder DM, Aitken JF.

J Adolesc Young Adult Oncol. 2019 Nov 25. doi: 10.1089/jayao.2019.0119. [Epub ahead of print]

PMID:
31765264
2.

Second primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based study.

Youlden DR, Baade PD, Green AC, Valery PC, Moore AS, Aitken JF.

Med J Aust. 2019 Nov 19. doi: 10.5694/mja2.50425. [Epub ahead of print]

PMID:
31743457
3.

Stage at diagnosis for childhood solid cancers in Australia: A population-based study.

Youlden DR, Frazier AL, Gupta S, Pritchard-Jones K, Kirby ML, Baade PD, Green AC, Valery PC, Aitken JF.

Cancer Epidemiol. 2019 Apr;59:208-214. doi: 10.1016/j.canep.2019.02.013. Epub 2019 Mar 1.

4.

Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.

Youlden DR, Gupta S, Frazier AL, Moore AS, Baade PD, Valery PC, Green AC, Aitken JF.

Pediatr Blood Cancer. 2019 Jun;66(6):e27683. doi: 10.1002/pbc.27683. Epub 2019 Feb 25.

PMID:
30803139
5.

The impact of reducing alcohol consumption in Australia: An estimate of the proportion of potentially avoidable cancers 2013-2037.

Wilson LF, Baade PD, Green AC, Jordan SJ, Kendall BJ, Neale RE, Olsen CM, Youlden DR, Webb PM, Whiteman DC.

Int J Cancer. 2019 Dec 1;145(11):2944-2953. doi: 10.1002/ijc.32204. Epub 2019 Feb 25.

PMID:
30748013
6.

Risk of Second Primary Cancer in Survivors of In Situ Melanoma.

Kimlin MG, Youlden DR, Brodie AM, DiSipio T, Youl P, Nair-Shalliker V, Baade PD.

J Invest Dermatol. 2019 Apr;139(4):842-847. doi: 10.1016/j.jid.2018.11.001. Epub 2018 Nov 10.

PMID:
30423330
7.

The impact of changing the prevalence of overweight/obesity and physical inactivity in Australia: An estimate of the proportion of potentially avoidable cancers 2013-2037.

Wilson LF, Baade PD, Green AC, Jordan SJ, Kendall BJ, Neale RE, Olsen CM, Youlden DR, Webb PM, Whiteman DC.

Int J Cancer. 2019 May 1;144(9):2088-2098. doi: 10.1002/ijc.31943. Epub 2018 Dec 3.

PMID:
30357816
8.

Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.

Brown CA, Youlden DR, Aitken JF, Moore AS.

Pediatr Blood Cancer. 2018 Dec;65(12):e27410. doi: 10.1002/pbc.27410. Epub 2018 Sep 5.

PMID:
30183136
9.

Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.

Aitken JF, Youlden DR, Moore AS, Baade PD, Ward LJ, Thursfield VJ, Valery PC, Green AC, Gupta S, Frazier AL.

Lancet Child Adolesc Health. 2018 Mar;2(3):173-179. doi: 10.1016/S2352-4642(18)30023-3. Epub 2018 Feb 1.

PMID:
30169253
10.

Variations in outcomes by residential location for women with breast cancer: a systematic review.

Dasgupta P, Baade PD, Youlden DR, Garvey G, Aitken JF, Wallington I, Chynoweth J, Zorbas H, Youl PH.

BMJ Open. 2018 Apr 29;8(4):e019050. doi: 10.1136/bmjopen-2017-019050.

11.

In response to: Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia.

Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM.

Int J Cancer. 2018 Aug 1;143(3):722-723. doi: 10.1002/ijc.31347. Epub 2018 Mar 12. No abstract available.

12.

Google as a cancer control tool in Queensland.

Huang X, Baade P, Youlden DR, Youl PH, Hu W, Kimlin MG.

BMC Cancer. 2017 Dec 4;17(1):816. doi: 10.1186/s12885-017-3828-x.

13.

Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.

Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM.

Int J Cancer. 2018 Apr 15;142(8):1528-1535. doi: 10.1002/ijc.31141. Epub 2017 Nov 21.

14.

Prognostic importance of a second invasive primary melanoma according to tumour stage.

Youlden DR, Baade PD, Aitken JF, Green AC, Khosrotehrani K.

Br J Dermatol. 2017 Dec;177(6):e336-e337. doi: 10.1111/bjd.15863. Epub 2017 Nov 14. No abstract available.

PMID:
28771669
15.

Variations in outcomes for Indigenous women with breast cancer in Australia: A systematic review.

Dasgupta P, Baade PD, Youlden DR, Garvey G, Aitken JF, Wallington I, Chynoweth J, Zorbas H, Roder D, Youl PH.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12662. Epub 2017 Feb 10. Review.

PMID:
28186346
16.

Response to Asgari.

Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K.

J Invest Dermatol. 2017 Apr;137(4):965-966. doi: 10.1016/j.jid.2016.12.003. Epub 2016 Dec 12. No abstract available.

17.

Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.

Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K.

J Invest Dermatol. 2016 Nov;136(11):2270-2276. doi: 10.1016/j.jid.2016.03.014. Epub 2016 Mar 24.

18.

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.

Cheng TY, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME.

J Thorac Oncol. 2016 Oct;11(10):1653-71. doi: 10.1016/j.jtho.2016.05.021. Epub 2016 Jun 27.

19.

Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.

Baade PD, Youlden DR, Andersson TM, Youl PH, Walpole ET, Kimlin MG, Aitken JF, Biggar RJ.

Cancer Causes Control. 2016 Aug;27(8):955-64. doi: 10.1007/s10552-016-0762-1. Epub 2016 Jun 15.

PMID:
27306518
20.

Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.

Youlden DR, Khosrotehrani K, Green AC, Soyer HP, Kimlin MG, Youl PH, Aitken JF, Baade PD.

Australas J Dermatol. 2016 Feb;57(1):57-60. doi: 10.1111/ajd.12429. Epub 2016 Jan 18.

PMID:
26776229
21.

Melanoma survival is superior in females across all tumour stages but is influenced by age.

Khosrotehrani K, Dasgupta P, Byrom L, Youlden DR, Baade PD, Green AC.

Arch Dermatol Res. 2015 Oct;307(8):731-40. doi: 10.1007/s00403-015-1585-8. Epub 2015 Jun 24.

PMID:
26103951
22.

Comparison of melanoma incidence and trends among youth under 25 years in Australia and England, 1990-2010.

Wallingford SC, Iannacone MR, Youlden DR, Baade PD, Ives A, Verne J, Aitken JF, Green AC.

Int J Cancer. 2015 Nov 1;137(9):2227-33. doi: 10.1002/ijc.29598. Epub 2015 May 29.

23.

Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.

Baade PD, Youlden DR, Andersson TM, Youl PH, Kimlin MG, Aitken JF, Biggar RJ.

BMJ Open. 2015 Apr 13;5(4):e006740. doi: 10.1136/bmjopen-2014-006740.

24.

The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.

Foresto SA, Youlden DR, Baade PD, Hallahan AR, Aitken JF, Moore AS.

Pediatr Blood Cancer. 2015 Sep;62(9):1664-6. doi: 10.1002/pbc.25517. Epub 2015 Apr 8.

PMID:
25855531
25.

Conditional survival estimates for childhood cancer in Australia, 2002-2011: A population-based study.

Youlden DR, Baade PD, Hallahan AR, Valery PC, Green AC, Aitken JF.

Cancer Epidemiol. 2015 Jun;39(3):394-400. doi: 10.1016/j.canep.2015.02.008. Epub 2015 Mar 11.

PMID:
25769222
26.

Assessment of the effect of migration on melanoma incidence trends in Australia between 1982 and 2010 among people under 30.

Baade PD, Youlden DR, Youl P, Kimlin M, Sinclair C, Aitken J.

Acta Derm Venereol. 2015 Jan;95(1):118-20. doi: 10.2340/00015555-1983. No abstract available.

27.
28.

Incidence and mortality of female breast cancer in the Asia-Pacific region.

Youlden DR, Cramb SM, Yip CH, Baade PD.

Cancer Biol Med. 2014 Jun;11(2):101-15. doi: 10.7497/j.issn.2095-3941.2014.02.005.

29.

Multiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982-2011.

Youlden DR, Youl PH, Peter Soyer H, Fritschi L, Baade PD.

J Invest Dermatol. 2014 Dec;134(12):2883-2889. doi: 10.1038/jid.2014.266. Epub 2014 Jul 3.

30.

Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.

Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD.

JAMA Dermatol. 2014 Aug;150(8):864-72. doi: 10.1001/jamadermatol.2014.124.

PMID:
24943712
31.

Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia.

Iannacone MR, Youlden DR, Baade PD, Aitken JF, Green AC.

Int J Cancer. 2015 Feb 1;136(3):603-9. doi: 10.1002/ijc.28956. Epub 2014 May 17.

32.

Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia.

Elwood JM, Youlden DR, Chelimo C, Ioannides SJ, Baade PD.

Cancer Epidemiol. 2014 Feb;38(1):16-21. doi: 10.1016/j.canep.2013.12.004. Epub 2014 Jan 18.

PMID:
24445141
33.

Epidemiology of prostate cancer in the Asia-Pacific region.

Baade PD, Youlden DR, Cramb SM, Dunn J, Gardiner RA.

Prostate Int. 2013;1(2):47-58. doi: 10.12954/PI.12014. Epub 2013 Jun 30. Review.

34.

International comparisons of the incidence and mortality of sinonasal cancer.

Youlden DR, Cramb SM, Peters S, Porceddu SV, Møller H, Fritschi L, Baade PD.

Cancer Epidemiol. 2013 Dec;37(6):770-9. doi: 10.1016/j.canep.2013.09.014. Epub 2013 Oct 16. Review.

PMID:
24138871
35.

The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.

Obermair A, Youlden DR, Baade PD, Janda M.

Int J Cancer. 2014 May 1;134(9):2211-22. doi: 10.1002/ijc.28537. Epub 2013 Oct 31.

36.

Cancer survival in Indigenous and non-Indigenous Australian children: what is the difference?

Valery PC, Youlden DR, Baade PD, Ward LJ, Green AC, Aitken JF.

Cancer Causes Control. 2013 Dec;24(12):2099-106. doi: 10.1007/s10552-013-0287-9. Epub 2013 Sep 14.

PMID:
24036890
37.

The validity of the distress thermometer in prostate cancer populations.

Chambers SK, Zajdlewicz L, Youlden DR, Holland JC, Dunn J.

Psychooncology. 2014 Feb;23(2):195-203. doi: 10.1002/pon.3391. Epub 2013 Sep 12.

38.

An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996-2009.

Dasgupta P, Youlden DR, Baade PD.

Cancer Causes Control. 2013 May;24(5):897-909. doi: 10.1007/s10552-013-0166-4. Epub 2013 Feb 14.

PMID:
23408244
39.

Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.

Baade PD, Youlden DR, Gardiner RA, Ferguson M, Aitken JF, Yaxley J, Chambers SK.

BJU Int. 2012 Dec;110(11 Pt B):E712-9. doi: 10.1111/j.1464-410X.2012.011533.x. Epub 2012 Sep 27.

40.

Cancer incidence and mortality in Indigenous Australian children, 1997-2008.

Valery PC, Youlden DR, Baade PD, Ward LJ, Green AC, Aitken JF.

Pediatr Blood Cancer. 2013 Jan;60(1):156-8. doi: 10.1002/pbc.24239. Epub 2012 Sep 26.

PMID:
23015533
41.

Childhood cancer mortality in Australia.

Youlden DR, Baade PD, Valery PC, Ward LJ, Green AC, Aitken JF.

Cancer Epidemiol. 2012 Oct;36(5):476-80. doi: 10.1016/j.canep.2012.06.001. Epub 2012 Jun 26.

PMID:
22739323
42.

Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996-2007.

Dasgupta P, Youlden DR, Baade PD.

Cancer Causes Control. 2012 Aug;23(8):1387-98. doi: 10.1007/s10552-012-9990-1. Epub 2012 May 22.

PMID:
22729930
43.

Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns.

Youl PH, Youlden DR, Baade PD.

Br J Dermatol. 2013 Jan;168(1):136-44. doi: 10.1111/j.1365-2133.2012.11064.x. Epub 2012 Sep 13.

PMID:
22612718
44.

The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD.

Cancer Epidemiol. 2012 Jun;36(3):237-48. doi: 10.1016/j.canep.2012.02.007. Epub 2012 Mar 27. Review.

PMID:
22459198
45.

Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: a large cohort study.

Baade PD, Gardiner RA, Ferguson M, Youlden DR, Aitken JF, Yaxley J, Chambers SK.

Cancer Causes Control. 2012 Apr;23(4):625-34. doi: 10.1007/s10552-012-9931-z. Epub 2012 Mar 2.

PMID:
22382868
46.

Differentials in survival for childhood cancer in Australia by remoteness of residence and area disadvantage.

Youlden DR, Baade PD, Valery PC, Ward LJ, Green AC, Aitken JF.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1649-56. doi: 10.1158/1055-9965.EPI-11-0432. Epub 2011 Jun 27.

47.

Urban-rural differences in prostate cancer outcomes in Australia: what has changed?

Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK.

Med J Aust. 2011 Mar 21;194(6):293-6.

PMID:
21426283
48.

Area-based differentials in childhood cancer incidence in Australia, 1996-2006.

Youlden DR, Baade PD, Valery PC, Hassall TE, Ward LJ, Green AC, Aitken JF.

Pediatr Blood Cancer. 2012 Mar;58(3):390-4. doi: 10.1002/pbc.23115. Epub 2011 Mar 21.

PMID:
21425449
49.

The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.

Youlden DR, Baade PD.

BMC Cancer. 2011 Feb 23;11:83. doi: 10.1186/1471-2407-11-83.

50.

When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects.

Baade PD, Youlden DR, Chambers SK.

Med J Aust. 2011 Jan 17;194(2):73-7. Erratum in: Med J Aust. 2011 Apr 4;194(7):376.

PMID:
21241220

Supplemental Content

Loading ...
Support Center